13.11.2014 Views

Huber - VascularWeb

Huber - VascularWeb

Huber - VascularWeb

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Access-related Hand Ischemia<br />

Thomas S. <strong>Huber</strong>, MD, PhD<br />

Professor of Surgery<br />

University of Florida College of Medicine<br />

Gainesville, Florida<br />

Postgraduate Course – SVS Annual Meeting<br />

Boston, Massachusetts


Disclosures<br />

None


Introduction<br />

• Hand ischemia - most worrisome<br />

“complication” after hemodialysis access.<br />

• Spectrum of symptoms (mild → severe).<br />

• “Complication” or adverse hemodynamic<br />

event within standard of care.<br />

*Access surgeons must be familiar with predictors, diagnosis, and treatment


Definitions and Classifications<br />

• Multiple terms and acronyms.<br />

– Access related ischemia (ARI)<br />

– Access related hand ischemia (ARHI)<br />

– Ischemic steal syndrome (ISS)<br />

– Dialysis associated steal syndrome (DASS)<br />

– Hemodialysis access induced distal ischemia (HAIDI)<br />

– Distal hypoperfusion ischemic syndrome (DHIS)<br />

*commonly described simply as “steal syndrome”


Definitions and Classifications<br />

• SVS Reporting Standards – “Steal”<br />

0 – none<br />

1 – mild cool extremity with few symptoms<br />

2 – moderate, ischemia during dialysis<br />

3 – severe, rest pain/tissue loss<br />

J Vasc Surg 2002;35:603.


Pathophysiology and Risk Factors<br />

• Low resistance circuit.<br />

• Distal perfusion<br />

variable, based on<br />

collaterals.<br />

• “Physiologic steal”<br />

usually tolerated.<br />

• Inflow/forearm PAOD<br />

decrease perfusion.<br />

*80% of patients with DBI – Vasc Endovasc Surg 2003;37:179


Pathophysiology and Risk Factors<br />

• Incidence (brachial artery-based access).<br />

– Symptoms 20%.<br />

– Intervention 10%.<br />

• Natural history poorly defined (selection).<br />

– Mild symptoms may improve.<br />

– Mod/serve symptoms do not improve.<br />

– Close follow-up mandatory<br />

*ischemia after radial-artery based access


Pathophysiology and Risk Factors<br />

• Clinical predictors<br />

– Advanced age<br />

– Female gender<br />

– Diabetes<br />

– Large conduit<br />

– PVOD<br />

– Multiple prior accesses<br />

– Prior hand ischemia<br />

• Noninvasive imaging<br />

– Finger pressure<br />

– DBI<br />

*Clinical factors, noninvasive studies with poor positive predictive value.


Clinical Presentation and Diagnosis<br />

• Classic symptoms<br />

(acute/chronic).<br />

• Clinical diagnosis –<br />

caution with pulses.<br />

• Limited differential.<br />

• Dialysis history key.<br />

• Noninvasive studies<br />

supportive.


Indications and Treatment<br />

• Goal - reverse ischemia/preserve access.<br />

• Indications – moderate/severe ischemia.<br />

• Multiple (complementary) treatments.<br />

*Ischemic neuropathy may not be reversible.


Indications and Treatment<br />

• Access ligation.<br />

• Correct inflow stenosis.<br />

• Flow-limiting (e.g. “banding”).<br />

• Proximalization of arterial inflow (PAI).<br />

• Ligation of artery distal to anastomosis.<br />

• Distal revascularization/interval ligation (DRIL).<br />

• Distal revascularization without ligation


Indications and Treatment<br />

• Hemodynamic impact – ex vivo.<br />

– Flow limiting effective.<br />

– DRIL and PAI with dramatic effect.<br />

– Ligation component of DRIL minimal effect.<br />

J Vasc Surg 2008;48:1559<br />

Ann Vasc Surg 2004;18:59


Indications and Treatment<br />

• Clinical determinants of treatment.<br />

– Cause of ischemia (possible inflow).<br />

– Potential utility of access.<br />

– Future access options (recurrence).<br />

– Patient comorbidities.<br />

– Available conduit.<br />

*DRIL for acute symptoms and reasonable autogenous access


Indications and Treatment<br />

• “Flow limiting” (banding).<br />

– Abandoned resurgence.<br />

– Balance perfusion/access flow.<br />

– Hemodynamics/biology dynamic.<br />

– Potential with objective measurements for<br />

“high flow” accesses (> 1.2 L/min)<br />

*Not effective for extensive tissue loss.<br />

J Vasc Surg 2006;44:1273<br />

Arch Surg 2007;392:204


Indications and Treatment<br />

• Proximalization of arterial inflow (PAI)<br />

– Variant of “flow limiting” procedure.<br />

– Does not require ligating axial artery.<br />

– Potential for patients without conduit.<br />

– Autogenous → prosthetic access.<br />

– Limited published experience.<br />

*Not effective for extensive tissue loss.<br />

J Vasc Surg 2006;43:1216<br />

Ann Vasc Surg 2008;23:485


Indications and Treatment<br />

• Distal revascularization/interval ligation<br />

– Most accepted/durable.<br />

– Requires ligating axial artery.<br />

– Hand dependent upon bypass.


Indications and Treatment<br />

• Preoperative (preemptive) planning.<br />

– Identify/correct all inflow lesions.<br />

– Operative plan to limit ischemia.<br />

– Remedial plan for ischemia.<br />

– Potential vein survey for DRIL.


UF DRIL - Patients<br />

Demographics N = 61<br />

Age 59 13<br />

Gender (% female) 62%<br />

Comorbidities<br />

ESRD 92%<br />

Hypertension 74%<br />

Diabetes Mellitus 72%<br />

Coronary Artery Disease 36%<br />

Congestive Heart Failure 20%<br />

Prior Access-related Ischemia 10%<br />

*6% of new access procedures required DRIL – J Vasc Surg 2008;48:926


UF DRIL - Procedures<br />

Auto Radiocephalic 0<br />

Auto Radiobasilic 0<br />

Auto Brachiocephalic 46%<br />

Auto Brachiobasilic 31%<br />

Auto BA Translocated Femoral 20%<br />

Prosthetic Brachioaxillary 3%<br />

J Vasc Surg 2008;48:926


Percentage (%)<br />

UF DRIL – Presenting Symptoms<br />

50<br />

40<br />

34<br />

30<br />

25<br />

24<br />

20<br />

17<br />

10<br />

0<br />

Pain Paresthesia Motor Tissue<br />

Loss<br />

*Preemptive DRIL N = 5<br />

J Vasc Surg 2008;48:926


Percentage (%)<br />

UF DRIL – Timing of Procedure<br />

50<br />

44<br />

40<br />

30<br />

29<br />

20<br />

19<br />

10<br />

0<br />

< 1 day 1 - 7 days 7 - 30 days > 30 days<br />

8<br />

J Vasc Surg 2008;48:926


UF DRIL - Technique<br />

• Proximal bypass<br />

anastomosis > 7cm<br />

from fistula.<br />

• Distal anastomosis<br />

functional end/end to<br />

brachial artery.<br />

• Autogenous v > 3 mm.<br />

• Inflow arteriogram.<br />

J Vasc Surg 2008;48:926


UF DRIL - Outcome<br />

Mortality 3%<br />

Morbidity 22%<br />

Wound 14%<br />

Respiratory 3%<br />

Vascular 3%<br />

Cardiac 2%<br />

J Vasc Surg 2008;48:926


UF DRIL - Outcome<br />

Paresthesia<br />

Motor<br />

Tissue Loss<br />

Pain<br />

None<br />

*Ischemic neuropathy may not be reversible.<br />

J Vasc Surg 2008;48:926


UF DRIL - Outcome<br />

1<br />

0.8<br />

* *<br />

0.79<br />

0.7<br />

0.6<br />

0.4<br />

0.46<br />

0.25<br />

Pre<br />

Post<br />

0.2<br />

0<br />

WBI<br />

FBI<br />

J Vasc Surg 2008;48:926


UF DRIL - Outcome<br />

Access – Immature<br />

(67%)<br />

Access – Mature<br />

(33%)<br />

Mature - 68% Fail - 32%<br />

Continue – 100% Early Failure - 0<br />

J Vasc Surg 2008;48:926


J Vasc Surg 2008;48:926


J Vasc Surg 2008;48:926


Summary/Conclusions<br />

• Access-related hand ischemia is an<br />

adverse hemodynamic event.<br />

• Predictable based upon patient<br />

characteristics and noninvasive studies.<br />

• Clinical diagnosis corroborated with<br />

noninvasive studies.


Summary/Conclusions<br />

• Goal to reverse ischemia/salvage access.<br />

• Multiple complementary treatment options<br />

• DRIL is a safe, effective treatment.<br />

– Symptomatic relief > 90%.<br />

– Acceptable bypass graft patency.<br />

– Preserves both hand and access.


Go GATORS


Case Presentation<br />

• HPI – 51 yo thin male with history of ESRD. Multiple<br />

failed LUE access procedures.<br />

• PMH – noncontributory.<br />

• PE – 2+ bilateral brachial/radial pulses. Multiple surgical<br />

incisions, palpable prosthetic access.<br />

• Vascular laboratory – no suitable peripheral veins,<br />

arterial pressures equal/symmetric, no central vein<br />

problems


Case Presentation - Continued<br />

• Surgical procedure – R brachioaxillary<br />

prosthetic access with 6 mm PTFE.<br />

• Perioperative outcome – grade III hand<br />

ischemia.<br />

• Vascular laboratory – no LE vein.


Case Presentation - Continued<br />

• Remedial treatment – arteriogram without<br />

inflow lesion, definitive treatment with<br />

ligation.<br />

• Approach to subsequent access.


Case Presentation<br />

• HPI – 60 year old obese female with ESRD for<br />

13 years, 57 prior access-related procedures<br />

currently dialyzing through a brachioaxillary<br />

prosthetic access (8 mm PTFE), venous<br />

anastomosis infraclavicular. Access noted be<br />

occluded at dialysis unit.<br />

• PE – obese female, multiple arm incisions,<br />

obvious graft thrombosis.


Case Presentation - Continued<br />

• Surgical procedure – open mechanical<br />

thrombectomy, venogram with central vein<br />

occlusion.


Case Presentation - Continued<br />

• Surgical procedure – central vein<br />

angioplasty with 14 mm balloon.<br />

• Remedial treatment

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!